Terns Pharmaceuticals Inc
NASDAQ:TERN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
360 Security Technology Inc
SSE:601360
|
CN |
|
T
|
Torunlar Gayrimenkul Yatirim Ortakligi AS
IST:TRGYO.E
|
TR |
During the last 3 months Terns Pharmaceuticals Inc insiders have not bought any shares, and sold 3m USD worth of shares. The stock price has increased by 42% over this period (open performance analysis).
The last transaction was made on
Apr 1, 2026
by
Kuriakose Emil
, who
sold
49.7k USD
worth of 
TERN shares.
During the last 3 months Terns Pharmaceuticals Inc insiders have not bought any shares, and sold 3m USD worth of shares. The stock price has increased by 42% over this period (open performance analysis).
The last transaction was made on
Apr 1, 2026
by
Kuriakose Emil
, who
sold
49.7k USD
worth of TERN shares.
Terns Pharmaceuticals Inc
Glance View
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The company is headquartered in Foster City, California and currently employs 41 full-time employees. The company went IPO on 2021-02-05. The firm is focused on developing a portfolio of small-molecule single-agent and combination therapy candidates to address diseases, such as non-alcoholic steatohepatitis (NASH) and obesity. Its lead program, TERN-101, is a liver-distributed, non-bile acid Farnesoid X Receptor (FXR), agonist that has demonstrated a differentiated tolerability profile and improved target engagement due to its sustained FXR activation in the liver but only transient FXR activation in the intestine. Its TERN-501 is a thyroid hormone receptor beta (THR-B) agonist with metabolic stability and improved liver distribution. Its TERN-201 is an inhibitor of vascular adhesion protein-1 (VAP-1) that has demonstrated target engagement in clinical trials. Its TERN-601 is its small-molecule Glucagon-Like Peptide-1 Receptor (GLP-1R) agonist program that is intended to be orally administered for NASH and obesity.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
